| Specialty Retail Industry | Consumer Discretionary Sector | Christopher Robin Haigh CEO | OTC PINK Exchange | 234263101 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Dakshidin Corporation, Inc., functioning through its subsidiaries, positions itself within the CBD and cannabis-based medical product industry. Initially known as Avrada, Inc., the company underwent a rebranding to Dakshidin Corporation, Inc. in February 2007, marking a significant pivot in its business focus. Based in Miami, Florida, and extending its presence through additional offices in Las Vegas, Nevada, the corporation engages in the cultivation of cannabis and extends its market reach through an online sales portal dedicated to CBD products. Moreover, Dakshidin Corporation, Inc. is actively involved in managing distribution channel programs spanning retail distribution, reselling, and direct sales market segments, further broadening its operational scope within the competitive landscape of CBD and cannabis-based products.
Dakshidin Corporation, Inc. offers a wide array of products and services, including: